Myelodysplastic Syndrome Clinical Trial

Clinical Trial Finder Myelodysplastic Syndrome Trials

Pegcetacoplan Early Access Program for PNH

See Locations Near You

Summary

This is an Early Access Program (EAP) which will provide access to pegcetacoplan for eligible participants with paroxysmal nocturnal hemoglobinuria (PNH).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with a confirmed diagnosis of PNH, who are transfusion dependent and are not responding to C5 treatment

Exclusion Criteria:

N/A

Study is for people with:

Myelodysplastic Syndrome

Study ID:

NCT04729062

Recruitment Status:

No longer available

Sponsor:

Apellis Pharmaceuticals, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Cancer Specialists of North Florida
Jacksonville Florida, 32256, United States
Tenneessee Oncology-Nashville
Nashville Tennessee, 37203, United States
Seattle Children's Hospital
Seattle Washington, 98105, United States
MultiCare Deaconess Cancer and Blood Specialty Center - North Spokane
Spokane Washington, 99204, United States

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Study ID:

NCT04729062

Recruitment Status:

No longer available

Sponsor:


Apellis Pharmaceuticals, Inc.

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider